X-46607060-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001257291.2(SLC9A7):āc.2073A>Gā(p.Arg691Arg) variant causes a synonymous change. The variant allele was found at a frequency of 0.000982 in 1,209,682 control chromosomes in the GnomAD database, including 12 homozygotes. There are 319 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0051 ( 5 hom., 141 hem., cov: 22)
Exomes š: 0.00057 ( 7 hom. 178 hem. )
Consequence
SLC9A7
NM_001257291.2 synonymous
NM_001257291.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.41
Genes affected
SLC9A7 (HGNC:17123): (solute carrier family 9 member A7) This gene encodes a sodium and potassium/ proton antiporter that is a member of the solute carrier family 9 protein family. The encoded protein is primarily localized to the trans-Golgi network and is involved in maintaining pH homeostasis in organelles along the secretory and endocytic pathways. This protein may enhance cell growth of certain breast tumors. This gene is part of a gene cluster on chromosome Xp11.23. A pseudogene of this gene is found on chromosome 12. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant X-46607060-T-C is Benign according to our data. Variant chrX-46607060-T-C is described in ClinVar as [Benign]. Clinvar id is 2043847.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00506 (564/111470) while in subpopulation AFR AF= 0.0178 (547/30666). AF 95% confidence interval is 0.0166. There are 5 homozygotes in gnomad4. There are 141 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC9A7 | NM_001257291.2 | c.2073A>G | p.Arg691Arg | synonymous_variant | 17/17 | ENST00000616978.5 | NP_001244220.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC9A7 | ENST00000616978.5 | c.2073A>G | p.Arg691Arg | synonymous_variant | 17/17 | 1 | NM_001257291.2 | ENSP00000480916.1 |
Frequencies
GnomAD3 genomes AF: 0.00504 AC: 562AN: 111416Hom.: 5 Cov.: 22 AF XY: 0.00417 AC XY: 140AN XY: 33598
GnomAD3 genomes
AF:
AC:
562
AN:
111416
Hom.:
Cov.:
22
AF XY:
AC XY:
140
AN XY:
33598
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00144 AC: 264AN: 183091Hom.: 0 AF XY: 0.000917 AC XY: 62AN XY: 67579
GnomAD3 exomes
AF:
AC:
264
AN:
183091
Hom.:
AF XY:
AC XY:
62
AN XY:
67579
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000568 AC: 624AN: 1098212Hom.: 7 Cov.: 32 AF XY: 0.000490 AC XY: 178AN XY: 363566
GnomAD4 exome
AF:
AC:
624
AN:
1098212
Hom.:
Cov.:
32
AF XY:
AC XY:
178
AN XY:
363566
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00506 AC: 564AN: 111470Hom.: 5 Cov.: 22 AF XY: 0.00419 AC XY: 141AN XY: 33662
GnomAD4 genome
AF:
AC:
564
AN:
111470
Hom.:
Cov.:
22
AF XY:
AC XY:
141
AN XY:
33662
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2023 | - - |
SLC9A7-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 17, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at